NCT06058663 2025-10-20Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic CholangiocarcinomaMayo ClinicPhase 1 Recruiting16 enrolled